Approval · Notice of Compliance 7310 · 2005
COVERSYL: Notice of Compliance 7310
Issued August 23, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7310
- Date
- August 23, 2005
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
Medicinal ingredients
- PERINDOPRIL ARGININE 2.5 MG per TAB
- PERINDOPRIL ARGININE 5 MG per TAB
- PERINDOPRIL ARGININE 10 MG per TAB